Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hollevoet, E. Kellen, K. Nackaerts, J. Thimpont, P. Germonpré, P. De Vuyst, L. Bosqueé, J. Delanghe, C. Legrand, J. P. van Meerbeeck (Ghent, Leuven, Brussels, Antwerp, Liège, Louvain-la-Neuve, Belgium). Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study. Eur Respir J 2009; 34: Suppl. 53, 3228

Member's Comments

No comment yet.

Related content which might interest you: Preliminary results of the French national prospective cohort on IPF Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol Source: Eur Respir J, 58 (3) 2100929; 10.1183/13993003.00929-2021 Year: 2021 Smartphone-enabled detection of COugh in COvid-19 (COCO) – preliminary analysis of an exploratory, observational cohort study Source: Virtual Congress 2021 – E-health for COVID-19 Year: 2021 Overview on observational studies Source: ERS Course 2015 Year: 2015 Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018 Year: 2018 Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study Source: Eur Respir J, 56 (6) 2003498; 10.1183/13993003.03498-2020 Year: 2020 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study. Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Protocol for the EARCO Registry: a pan-European observational study in patients with a1-antitrypsin deficiency Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019 Year: 2020 Observational, multicentre study on the epidemiology of haemoptysis Source: Eur Respir J, 51 (1) 1701813; 10.1183/13993003.01813-2017 Year: 2018 The AMBITION study: design and results Source: International Congress 2014 – Combination therapy in pulmonary arterial hypertension (PAH): the evidence grows Year: 2014 A new prospective multicenter study of EBV treatment of homogeneous disease: A status report Source: Annual Congress 2013 –Endoscopic lung volume reduction & newest clinical data Year: 2013 Study design: features of non-experimental studies Source: Eur Respir Monogr 2014; 65: 249-256 Year: 2014 Assessment of the association between asthma and malignancy: a population-based retrospective matched cohort study Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009 Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019